Pleiotropic tumor suppressive functions of PTEN missense mutations during gliomagenesis

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• PTEN is a critical tumor suppressor gene frequently altered in glioblastoma (GBM).
• Missense mutations in PTEN are common in GBM but their functional impact remains largely uncharacterized.
• EGFR signaling is a key driver in GBM pathogenesis.

Purpose of the Study:

• To investigate the role of specific, clinically relevant PTEN missense mutations in the development of EGFR-driven GBM.
• To elucidate the molecular mechanisms by which these PTEN mutants contribute to GBM.
• To identify potential therapeutic targets for GBM with PTEN alterations.

Main Methods:

• Utilized genetically modified mouse models and isogenic astrocyte cell cultures.
• Analyzed PTEN mutants (G36E, L42R, C105F, R173H) in the context of EGFR-driven GBM.
• Performed global protein phosphorylation and kinase library analyses.

Main Results:

• PTEN mutant tumor suppressive function loss is linked to increased cell membrane localization, not lipid phosphatase activity.
• PTEN mutations enhance EGFR activity by prolonging EGFR sequestration in endomembranes.
• Identified distinct EGFR-activated, cancer-promoting pathways in cells with G36E and L42R PTEN mutations.

Conclusions:

• Specific PTEN mutations promote GBM through mechanisms independent of lipid phosphatase activity.
• Altered PTEN localization and subsequent EGFR hyperactivity drive GBM development.
• Targeting identified cancer-promoting pathways may offer new therapeutic strategies for GBM patients with PTEN alterations.